VOLUME 11 NUMBER 3 MARCH 2010 nature immunology CD8 + T cell priming to influenza requires antigen presentation by activated dendritic cells (DCs) 1-4 that express costimulatory molecules, such as CD40, CD80 and CD86, which promote T cell proliferation and differentiation. Some activated DCs also express CD70 (A000547), the ligand for the receptor CD27 (A000546), which facilitates primary and secondary CD8 + T cell responses 5-8 . However, it remains unclear which DCs express CD70 and how CD70 expression affects their ability to promote CD8 + T cell proliferation and differentiation.
CD8 + T cell priming to influenza requires antigen presentation by activated dendritic cells (DCs) 1-4 that express costimulatory molecules, such as CD40, CD80 and CD86, which promote T cell proliferation and differentiation. Some activated DCs also express CD70 (A000547), the ligand for the receptor CD27 (A000546), which facilitates primary and secondary CD8 + T cell responses [5] [6] [7] [8] . However, it remains unclear which DCs express CD70 and how CD70 expression affects their ability to promote CD8 + T cell proliferation and differentiation.
In lymph nodes, DCs can be broadly separated into resident DCs, which differentiate locally from precursors that enter lymph nodes from the blood, and migratory or tissue DCs (tDCs), which differentiate in peripheral tissues and, after activation, migrate into draining lymph nodes through afferent lymphatics 3, 9, 10 . Lymph node-resident DCs include plasmacytoid DCs and conventional DCs (cDCs), which can be subdivided on the basis of CD8α and CD4 expression 3 . The tDC subset can also be subdivided on the basis of expression of the integrin α E β 7 (CD103; A001208) 11, 12 . In the lung, CD103 + CD11b lo tDCs are located in the airway mucosa between epithelial cells, whereas CD103 − CD11b hi tDCs are located in the submucosa and lung parenchyma 11, 13 . Although trafficking of pulmonary tDCs to the mediastinal lymph nodes (mLNs) is essential for the generation of adaptive immunity, the roles of various DC subsets in CD8 + T cell responses are not fully understood 12, [14] [15] [16] [17] [18] .
CD8 + T cells respond to a wide variety of antigens, some of which are not expressed by DCs. Thus, DCs must have a way of acquiring external antigens and processing these in the major histocompatibility complex (MHC) class I pathway, a process known as cross-presentation 2, 3, 19 . The present paradigm suggests that CD8α + cDCs are responsible for crosspriming CD8 + T cells to influenza virus 16, [20] [21] [22] [23] , a model inconsistent with the idea that CD8α + cDCs are lymph node-resident DCs and do not traffic through peripheral tissues. However, tDCs may carry antigens from the lungs, home to the lymph nodes and transfer antigen to CD8α + cDCs, which then cross-prime CD8 + T cells 3, 16, [23] [24] [25] . Subsequent studies have challenged that model and suggest that some CD8α − migratory DCs directly participate in cross-presentation 14, 17, 26 . Thus, the ability of various DC subsets to acquire antigen in the lungs, express the appropriate costimulatory molecules and cross-prime CD8 + T cell responses remains unclear.
Here we show that early after pulmonary influenza infection, both CD103 + CD11b lo and CD103 − CD11b hi tDCs, but not CD8α + cDCs, migrated from the lung to the mLNs and presented influenza nucleoprotein (NP). However, CD103 -CD11b hi tDCs rapidly accumulated in the mLNs and lungs and, at the peak of infection, completely dominated the presentation of NP. Moreover, CD103 − CD11b hi tDCs efficiently captured exogenous antigens in the lungs, processed these antigens into the MHC class I pathway, migrated to the draining lymph nodes and cross-primed CD8 + T cells. Finally, we show that CD103 − CD11b hi tDCs were the only DCs that upregulated CD70 after influenza infection and that CD70 expression on CD103 − CD11b hi tDCs was functionally important for CD8 + T cell responses to both influenza NP and exogenous ovalbumin (OVA). Together our results establish a new paradigm in which DC subsets acquire exogenous and virus-derived antigens in the lungs and cross-prime CD8 + T cell responses.
RESULTS

Kinetics of the NP-specific CD8 + T cell response
To determine the kinetics of the CD8 + T cell response to influenza NP, we infected C57BL/6 mice with influenza strain A/PR8/34 (PR8) and counted NP-specific CD8 + T cells in the draining mLNs and lungs. We first observed NP-specific CD8 + T cells in the mLNs between days 3 and 5 after infection (Fig. 1a) , a time at which NP-specific CD8 + T cells in the lung were still undetectable by flow cytometry (Fig. 1b) . However, we observed increases in NP-specific CD8 + T cells in both mLNs and lungs between days 5 and 10, when NP-specific CD8 + T cells were rapidly proliferating in both organs (data not shown). The number of NP-specific CD8 + T cells peaked 10 d after infection in the mLNs ( Fig. 1a ) and 12 d after infection in the lungs (Fig. 1b) . These data are consistent with the idea that influenza-specific CD8 + T cells are first primed in the draining mLNs before homing to the lungs, where they continue to proliferate and perform their effector functions.
DC subsets in the mLNs after influenza virus infection
Because T cells are primed by DCs, we next characterized DC subsets in the mLNs. We identified three main populations of DCs in the mLNs on the basis of expression of CD11c and MHC class II (MHCII; Fig. 2a , left). The main subset consisted of MHCII hi CD11c med B220 − cells, which seemed to be migratory tDCs that arrived from the lungs 3, 27 . We further divided the tDCs into two subpopulations on the basis of CD103 expression. The MHCII hi CD11c med B220 − CD103 + tDCs had low expression of CD11b and Ly6C and were designated CD103 + CD11b lo tDCs, whereas the MHCII hi CD11c med B220 − CD103 − tDCs had abundant expression of CD11b and intermediate expression of Ly6C and were designated CD103 − CD11b hi tDCs. These latter cells are similar to MHCII hi CD11c med CD11b hi Ly6C med dermal monocyte-derived DCs 10 . Notably, we detected weak CD8α expression on both CD103 − CD11b hi and CD103 + CD11b lo tDCs (Supplementary Fig. 1a ). We also observed MHCII med CD11c hi B220 − DCs, which seemed to correspond to resident cDCs that differentiated locally in the lymph nodes from blood-derived precursors 3 . We subdivided this population into three subsets: CD11b lo CD4 − CD8α + Ly6C lo cells, which we called CD8α + cDCs; CD11b hi CD4 + CD8α − Ly6C lo cells, which we A r t i c l e s called CD4 + cDCs; and CD11b hi CD4 − CD8α − Ly6C lo cells, which we called doublenegative cDCs. Whereas double-negative cDCs and CD4 + cDCs did not express CD103, CD8α + cDCs could be further subcategorized as CD103 + and CD103 − CD8α + cDCs on the basis of CD103 expression ( Supplementary Fig. 1b ). Finally, we identified MHCII med CD11c med B220 -CD11b hi CD4 − CD8α lo CD103 − Ly6C hi DCs, which seemed to correspond to inflammatory DCs (iDCs) that differentiated locally in the lymph nodes from bloodrecruited monocytes 9, 10 .
As expected, the total number of DCs in the mLNs increased after influenza infection, peaking between days 5 and 10 after infection ( Fig. 2b) , the same time that NP-specific CD8 + T cells were proliferating in the mLNs. However, the accumulation of the various cDC subsets was not equal. In particular, CD103 − CD11b hi tDCs were the most numerous after influenza infection, whereas CD8α + cDCs and CD103 + CD11b lo tDCs were minor populations ( Fig. 2b) .
CD103 − CD11b hi tDCs migrate to the mLNs
The migration of DCs from peripheral tissues to draining lymph nodes is important for the priming of T cell responses. To determine which DC subsets were recruited from lungs to the mLNs after influenza infection, we instilled carboxyfluorescein succinimidyl ester (CFSE) intranasally into the lungs of influenza-infected mice and counted CFSE + CD11c + DCs in the mLNs 16 h later. Our results showed that although virus infection quickly enhanced the recruitment of DCs from the lungs to the mLNs (Fig. 3a) , migratory flux was maximum on day 5 after infection. Most migratory DCs were MHCII hi CD11c med tDCs ( Fig. 3b) and relatively few were MHCII med CD11c hi cDCs or MHCII med CD11c med iDCs.
We next determined whether CD103 was expressed on the tDCs that migrated from the lungs to the mLNs. We found that CD103 + CD11b lo tDCs constituted around 40% of tDCs recruited into the mLNs immediately after infection ( Fig. 3c) . However, the migration of CD103 − CD11b hi tDCs progressively outpaced that of CD103 + CD11b lo tDCs cells, and by day 5, CD103 − CD11b hi tDCs constituted 80-85% of the CFSE-labeled DCs recruited from the lungs (Fig. 3c) . In fact, CD103 − CD11b hi tDCs were the dominant DC population recruited to the mLNs from the lungs after influenza infection ( Fig. 3d) .
To confirm that the CD103 − CD11b hi tDCs were actually migrating from the lungs rather than simply acquiring CFSE in the mLNs, we purified total CD11c + DCs from the lungs of CD45.2 + C57BL/6 mice that had been infected with influenza 5 d before and transferred them intranasally into influenza-infected CD45.1 + recipient mice. We then determined the frequency of donor CD103 + CD11b lo and CD103 − CD11b hi tDCs in the mLNs 24 h after adoptive transfer. We found that both CD103 − CD11b hi and CD103 + CD11b lo tDCs migrated to the mLNs of recipient mice ( Fig. 3e) . Although the majority (86%) of the tDCs that migrated to the mLNs lacked CD103 expression, this frequency was similar to the frequency of CD103 − CD11b hi tDCs in the transferred population (data not shown). Thus, both CD103 + CD11b lo and CD103 − CD11b hi tDCs migrate from the lungs to the mLNs, but the CD103 − CD11b hi subset is recruited in greater numbers during the peak of infection.
CD103 − CD11b hi tDCs accumulate in the lungs
The 'preferential' accumulation of CD103 − CD11b hi tDCs in the mLNs after influenza infection could reflect changes in DC populations in the lungs. To test this possibility, we counted cells in DC subsets in the lungs after influenza infection. Lung macrophages and DCs express similar amounts of CD11c 28 . Therefore, we initially excluded macrophages on the basis of autofluorescence and then gated on MHCII + CD11c + DCs (Fig. 4a, left) , which we separated into B220 − DCs and B220 + plasmacytoid DCs. We further subdivided the B220 − subset into CD103 − CD11b hi tDCs and CD103 + CD11b lo tDCs.
Under steady-state conditions, we found that the CD103 + CD11b lo tDCs represented about 30% of total tDCs in the lungs (Fig. 4b , left). However, infection altered the ratio of CD103 + CD11b lo and CD103 − CD11b hi tDCs such that the CD103 − CD11b hi tDCs represented more than 90% of the tDCs in the lungs by day 5 after infection ( Fig. 4b) . Influenza virus infection triggered the accumulation of CD103 − CD11b hi tDCs in the lungs (Fig. 4c) , which peaked 7 d after infection. In contrast, the number of CD103 + CD11b lo was lower after influenza infection ( Fig. 4d) , which suggested that the greater number of CD103 − CD11b hi tDCs in the mLNs after influenza infection was a consequence of greater numbers of CD103 − CD11b hi tDCs in the lungs that migrated to the mLNs.
CD103 − CD11b hi tDCs present NP to CD8 + T cells
The simultaneous accumulation of CD103 − CD11b hi tDCs and NPspecific CD8 + T cells in the mLNs suggested a prominent role for this DC subset in antigen presentation. To test this possibility, we sorted DC subsets from the mLNs of infected mice and cultured them together with CFSE-labeled CD8 + T cells from the mLNs of mice infected 7 d before. We found that before culture, the input CD8 + T cell population contained about 2% NP-specific T cells ( Fig. 5a ). When cultured for 3 d with control DCs from uninfected mice, the NP-specific CD8 + T cells failed to proliferate (Fig. 5b) . When cultured with DC subsets from infected mice, only tDCs ( Fig. 5c,d) , but not CD8α + cDCs (Fig. 5e ), CD8α − cDCs ( Fig. 5f ) or iDCs ( Supplementary Fig. 2) , induced substantial CD8 + T cell proliferation. Notably, whereas both CD103 − CD11b hi and CD103 + CD11b lo tDCs equally induced NP-specific CD8 + T cell proliferation 3 d after infection (Fig. 5g) , the capacity of CD103 + CD11b lo tDCs to expand NP-specific CD8 + T cell populations decreased considerably by days 5 and 7 after infection ( Fig. 5h,i) . In contrast, CD103 − CD11b hi tDCs retained their ability to present NP on days 5 and 7 after infection ( Fig. 5h,i) . Given that CD103 − CD11b hi tDCs were much more abundant in the mLNs than were other DC subsets ( Fig. 2b) and that CD103 − CD11b hi tDCs primed NP-specific CD8 + T cell proliferation more efficiently than did the other DC subsets in the mLNs at the peak of T cell response ( Fig. 5) , our results suggest that CD103 − CD11b hi tDCs are central participants in CD8 + T cell responses to influenza infection.
CD103 − CD11b hi tDCs cross-present antigens to CD8 + T cells
Published reports have suggested that migratory DCs obtain exogenous antigens in infected tissues, migrate to the corresponding draining lymph nodes and efficiently prime CD8 + T cells by crosspresentation 14, 17, 26 . To test whether antigens captured in the lungs could be cross-presented to CD8 + T cells in the mLNs after influenza infection, we adoptively transferred CFSE-labeled OVA-specific OT-I cells into recipient mice that had been infected with influenza 4 d earlier.
We then administrated 60 µg of soluble OVA or PBS intranasally the next day and analyzed the proliferation of the transferred cells in the mLNs 72 h later. We observed robust proliferation of OT-I cells in OVA-treated mice but not in PBS-treated mice (Fig. 6a) , which demonstrated that exogenous antigens in the lungs were efficiently cross-presented to CD8 + T cells. As the OT-I cells used in the previous experiment were not on a recombination-activating gene 1-deficient background, they probably included some antigen-experienced cells. To assess whether naive OT-I cells could proliferate in response to exogenous OVA, we purified CD44 lo OT-I cells ( Supplementary  Fig. 3a ) and repeated the experiment described above. Consistent with our earlier results, we found that naive OT-I cells could be primed by exogenous OVA delivered to the lungs (Supplementary Fig. 3b ).
To track the DCs responsible for cross-presentation, we administered soluble fluorescein isothiocyanate-labeled OVA (FITC-OVA) intranasally to mice 5 d after virus infection, purified CD11c + cells from the mLNs and used them as antigen-presenting cells for CFSElabeled OT-I cells in vitro. We found that OT-I cells proliferated rapidly when primed with CD11c + cells from the mLNs of mice that had been given FITC-OVA, whereas OT-I cells did not proliferate when cultured with CD11c + cells from PBS-treated mice (Fig. 6b) . To determine which DC subset was responsible for cross-presentation, A r t i c l e s we analyzed which DCs acquired FITC-OVA. We found that only tDCs and not cDCs or iDCs acquired FITC-OVA ( Fig. 6c) , which suggested that only the DCs that migrated from the lungs were able to present lung-derived antigens to CD8 + T cells. However, published studies have suggested that migratory DCs do not directly cross-present antigen to CD8 + T in the draining lymph nodes but transfer those antigens to resident CD8α + cDCs, which cross-prime CD8 + T cells 16, 24, 25 .
To directly determine which DCs were responsible for cross-priming CD8 + T cells, we sorted DC subsets from the mLNs of mice that had been administered OVA intranasally 5 d after influenza infection and used those cells to prime CFSE-labeled OT-I cells in vitro. Whereas sorted tDCs induced the proliferation of OT-I cells (Fig. 6d) , neither CD8α + cDCs nor CD8α − cDCs were effective. However, failure of cDC subpopulations to prime OT-I cells was not due to an inability to stimulate CD8 + T cells, as inclusion of exogenous OVA peptide (amino acids 257-264) induced similar proliferation of OT-I cells when cultured with any of the DC subsets (Fig. 6e) . These data suggest that tDCs are the main DC population that acquires soluble antigens in the lungs and cross-primes CD8 + T cells.
Although it was clear that tDCs were the main DC population that captured and cross-presented antigens from the lungs, it was not clear whether some of the cDCs also had cross-priming ability but did not have access to antigens from the lungs. To directly test whether tDCs and cDCs had similar abilities to cross-present antigens, we sorted DC subpopulations from the mLNs of mice infected with influenza 5 d earlier, pulsed them in vitro with soluble OVA and cultured them together with CFSE-labeled OT-I cells or CFSE-labeled OT-II CD4 + T cells. We found that tDCs, particularly CD103 -CD11b hi tDCs, were more efficient than either CD8α + cDCs or CD8α − cDCs at cross-presenting soluble OVA (Fig. 6f, top, and 6g) . In contrast, we detected no difference in antigen-presenting ability when we pulsed DC subsets with OVA peptide (amino acids 257-264; data not shown). Moreover, CD8α + cDCs, CD8α − cDCs and CD103 − CD11b hi tDCs efficiently presented soluble antigen to OT-II cells, whereas CD103 + CD11b lo tDCs were only modestly effective (Fig. 6f, bottom, and 6h) . We also did this same experiment with sorted CD44 lo naive OT-I cells (Supplementary Fig. 3c ) and again found that CD103 − CD11b hi tDCs most efficiently primed naive OT-I cells (Supplementary Fig. 3d,e ). CD103 + CD11b lo tDCs also primed naive OT-I cells, albeit less efficiently, but neither CD8α + cDCs nor CD8α − cDCs were able to prime naive OT-I cells ( Supplementary  Fig. 3d,e) . Together our results demonstrate that CD103 − CD11b hi tDCs efficiently capture antigens from the lungs, migrate to the draining mLNs and cross-prime CD8 + T cells.
CD70 expression on CD103 − CD11b hi tDCs
To better understand the role of migratory lung DCs in immunity to influenza, we evaluated the maturation of CD103 − CD11b hi and CD103 + CD11b lo tDCs in the mLNs after influenza infection. We found that the kinetics of CD40 expression were almost identical for both CD103 + CD11b lo and CD103 − CD11b hi tDC populations, with the peak of CD40 expression occurring between days 3 and 7 after infection (Fig. 7a) . Although CD86 expression peaked earlier than CD40 expression, its expression was also nearly identical on both 29 2.05 A r t i c l e s CD103 + CD11b lo and CD103 − CD11b hi tDCs (Fig. 7b) . In contrast, the expression of CD70, the ligand for CD27 (ref. 29) , was higher on CD103 − CD11b hi tDCs and not on CD103 + CD11b lo tDC (Fig. 7c) , with maximum expression of CD70 at 5 d after infection (Fig. 7c,d) .
Unlike published studies 17 , we did not observe CD70 on either CD8α + or CD8α − cDCs at any time point after infection ( Supplementary  Fig. 4) . Thus, CD103 − CD11b hi tDCs seemed to be the primary migratory DC subset that expressed the costimulatory molecule CD70 after influenza infection.
Although it was clear that CD70 was uniquely expressed on CD103 − CD11b hi cells in the draining lymph nodes, it was not clear whether these cells were derived from CD70-expressing cells in the lungs or whether CD70 expression was acquired in the lymph nodes or in transit from the lungs to the lymph nodes. Therefore, we next analyzed CD70 expression on CD103 − CD11b hi cells in the lungs. We found that CD70 was expressed with similar kinetics and on similar frequencies of CD103 − CD11b hi cells in the lungs and mLNs (Fig. 7e) , which suggested that CD70 was initially expressed in the lungs on CD103 − CD11b hi cells before their migration to the mLNs. To demonstrate that CD70 cells in the draining lymph nodes were recently derived from the lungs, we administered CFSE intranasally into the lungs of influenza infected mice and then determined the frequency of CD70-expressing cells in the CFSE-labeled CD103 − CD11b hi tDC population. We found that nearly 60% of the CFSE-labeled CD103 − CD11b hi cells in the lymph nodes expressed CD70 on day 5 (Fig. 7f) , which again suggested that these cells had recently migrated from the lungs.
CD70-CD27 interactions have a central role in both primary and secondary CD8 + T cell responses to influenza 5, 6 . To assess whether CD27 expression correlated with the proliferation of CD8 + T cells, we assayed the incorporation of 5-ethynyl-2′-deoxyuridine (EdU) and expression of CD27 by NP-specific CD8 + T cells. We found that most NP-specific CD8 + T cells had abundant coexpression of CD44 and CD27 and that more than 80% of these cells incorporated EdU during a 16-hour pulse (Fig. 7g) . We also found relatively high expression of CD27 on CD44 hi CD8 + T cells that were not specific for NP. However, CD27 expression was substantially lower on CD44 lo CD8 + T cells (Fig. 7g) , probably because many of these cells were not responding to influenza. Notably, of the CD44 hi NP-nonspecific CD8 + T cells, those with high expression of CD27 incorporated EdU at a much higher frequency than did those with lower expression of CD27 (Fig. 7g) . We obtained similar results when we examined NP-specific CD8 + T cells in the lungs on day 7 after influenza infection (Supplementary Fig. 5) . Thus, CD27 expression seems to correlate with the proliferation of effector CD8 + T cells.
CD70 promotes population expansion of NP-specific CD8 + T cells
To address whether CD70-CD27 interactions were required for NP-specific CD8 + T cell proliferation, we first blocked CD70-CD27 
A r t i c l e s in vitro. We found that the ability of CD103 − CD11b hi tDCs to promote the proliferation of NP-specific CD8 + T cells was markedly inhibited by antibody to CD70 (anti-CD70; Fig. 8a ). Next we analyzed whether cross-presentation of soluble antigens by CD103 − CD11b hi tDCs required CD70 expression. We found that CD103 − CD11b hi tDCs pulsed with soluble OVA strongly promoted the proliferation of OT-I cells in the presence of control antibody but not in the presence of anti-CD70 (Fig. 8b) . To address whether the late expansion of NP-specific CD8 + T cell populations was dependent on CD70 expression in vivo, we treated influenza-infected mice with anti-CD70 4 d after primary infection and determined the frequency of NP-specific CD8 + T cells 6 d after antibody administration (day 10 after infection). We observed considerably fewer NP-specific CD8 + T cells in mice treated with anti-CD70 than in mice treated with isotype-matched control antibody (Fig. 8c) , which confirmed that the in vivo population expansion of influenza NP-specific CD8 + T cells was dependent on CD70-CD27 interactions.
DISCUSSION
Our results have demonstrated that CD103 − CD11b hi tDCs have a critical role in NP-specific CD8 + T cell population expansion after pulmonary influenza infection. These results differ from published findings in several respects. First, we found that the migration of DCs from the lungs to the mLNs continued to increase through day 5 after influenza infection, rather than peaking in the first day or two 30 . Notably, the DCs migrating from the lungs to the mLNs during this time included both CD103 + CD11b lo tDCs and CD103 − CD11b hi tDCs, both of which are potent antigen-presenting cells. These results are consistent with other reports showing that tissue-derived CD103 + DCs present antigen in draining lymph nodes immediately after infection or immunization 14, 18 . However, we found that the CD103 − CD11b hi tDCs migrating from the lungs to the lymph nodes vastly outnumbered the CD103 + CD11b lo cells by day 5 after infection and were more potent antigen-presenting cells than were CD103 + CD11b lo tDCs on a per-cell basis. Thus, CD103 − CD11b hi tDCs take over antigen presentation in the mLNs during the peak of the response.
Although we did not explicitly examine the cellular origin of the CD103 − CD11b hi tDCs in the mLNs, they are probably similar to the MHCII hi CD11c med CD11b hi Ly6C med DCs described after Leishmania major infection 10 . These dermal monocyte-derived DCs are recruited to the dermis and differentiate locally into DCs. After activation, they migrate to the draining lymph node and present antigen to T cells. In a parallel way, we suggest that influenza infection leads to the recruitment of monocyte precursors to the lungs, which differentiate locally into CD103 − CD11b hi tDCs. Once activated, the CD103 − CD11b hi tDCs in the lungs then migrate to the draining mLNs, where they present antigen to CD8 + T cells.
Notably, CD103 + CD11b lo and CD103 − CD11b hi tDCs develop from different monocyte precursors 31,32 that seem to respond to different growth factors. For example, the ligand for the cytokine receptor Flt3 promotes the population expansion of CD11b hi DCs but not CD11b lo DCs in the lungs 33 , whereas epithelium-derived factors such as transforming growth factor-β and retinoic acid promote the differentiation of CD103 + tDCs 34, 35 . Given that influenza infection destroys the respiratory epithelium, it is possible that alterations in pulmonary cytokine expression after influenza infection promotes the accumulation of CD103 − CD11b hi tDCs at the expense of CD103 + CD11b lo tDCs. Selective exposure of CD103 + CD11b lo tDCs to influenza in the epithelium 11 also probably makes them highly susceptible to infection, whereas the CD103 − CD11b hi tDCs in the lung parenchyma probably remain uninfected 36 . The placement of CD103 + CD11b lo tDCs in the epithelium allows them to effectively acquire antigen and prime CD8 + T cells when the epithelium is intact, such as after exposure to inert antigens 37 or perhaps after infection with nonlytic viruses 14, 18 or very early after influenza infection 14 . In contrast, CD103 − CD11b hi tDCs are thought to promote tolerance or 'preferentially' prime CD4 + T cells under steady-state conditions 37 . However, CD103 − CD11b hi tDCs probably progressively gain access to influenza antigens once the epithelium is disrupted. Thus, temporal changes in growth-promoting cytokines, susceptibility to infection and antigen availability allow CD103 − CD11b hi tDCs to dominate the late stages of antigen presentation to CD8 + T cells after influenza infection.
CD8α + cDCs are often suggested to be the main DC subset able to cross-prime CD8 + T cells 16, [20] [21] [22] [23] 38 . However, we have found that early after influenza infection, both CD103 + CD11b lo tDCs and CD103 − CD11b hi tDCs, but not CD8α + cDCs, acquired soluble antigen in the lungs, migrated to the mLNs and cross-primed CD8 + T cells directly, without handing off antigen to other DCs. Although these results contradict the prevailing dogma, the role of DC subsets in cross-priming CD8 + T cell responses depends on how antigen is delivered and how DCs are activated. For example, plasmacytoid DCs 39,40 , CD8α − cDCs 41, 42 and monocyte-derived migratory DCs 14, 17, 26 can efficiently cross-present exogenous antigens in some circumstances. Moreover, although CD8α + cDCs are the only DCs to cross-prime influenza-specific CD8 + T cells after intravenous or subcutaneous infection 20 , both CD8α + DCs and airway-derived CD8α − CD11b lo DCs prime CD8 + T cells after intranasal infection 16 . Even the ability of CD8α + DCs to cross-prime CD8 + T cells to soluble OVA depends on the lymphoid organ from which they are isolated 43 . Thus, cross-priming by DCs can be strongly influenced by how DCs acquire antigen and the type of antigen they encounter.
The contradictory results concerning the role of CD8α + DCs in cross-priming may also be partly attributed to the methods used to phenotype DC subsets. Many authors sort bulk CD8α + CD11c + DCs or deplete CD8α + cells from total CD11c + cells and then test cross-priming activity. However, we found that CD103 + CD11b lo tDCs, CD103 − CD11b hi tDCs and even iDCs all had moderate expression of CD8α 14, 41 . As a result, the purification of bulk CD8α + CD11c + cells without additional characterization using other markers will probably result in a mixed population of CD8α + DCs and tDCs. Similarly, the expression of CD11b does not distinguish many of the DC subsets described here without the use of additional markers, such as MHCII and CD11c. Using a multiparameter sorting strategy, we and others 14 have separated true CD8α + cDCs from other DC subsets that may have low expression of CD8α.
Together our results suggest a new paradigm for how DC subsets promote pulmonary CD8 + T cell responses. Initial immune responses to lytic viruses such as influenza are initiated by both CD103 + CD11b lo tDCs and CD103 − CD11b hi tDCs, which acquire antigen in the lungs, migrate to the mLNs and prime CD8 + T cells. CD103 + CD11b lo tDCs are soon depleted from the lungs and are poorly replenished. As a result, CD103 − CD11b hi tDCs rapidly become the main DC subset that acquires virus-derived and exogenous antigens and cross-primes CD8 + T cells directly, without handing off antigen to CD8α + cDCs. Once virus infection is cleared and the epithelium is repaired, CD103 + CD11b lo tDCs are restored to the lungs and homeostasis is re-established.
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